Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""101140988"" wg kryterium: JN


Tytuł:
Extranodal Rosai-Dorfman disease involving pulmonary artery detected by Ga-FAPI PET/MRI.
Autorzy:
Zhao L; Department of Nuclear Medicine & Minnan PET Center, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Teaching Hospital of Fujian Medical University, Xiamen, China.; Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and Faculty of Engineering, National University of Singapore, Singapore, Singapore.; Department of Radiation Oncology, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Teaching Hospital of Fujian Medical University, Xiamen, China.
Pang Y; Department of Nuclear Medicine & Minnan PET Center, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Teaching Hospital of Fujian Medical University, Xiamen, China.; Department of Radiation Oncology, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Teaching Hospital of Fujian Medical University, Xiamen, China.
Sun L; Department of Nuclear Medicine & Minnan PET Center, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Teaching Hospital of Fujian Medical University, Xiamen, China.
Lin Q; Department of Radiation Oncology, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Teaching Hospital of Fujian Medical University, Xiamen, China.
Chen H; Department of Nuclear Medicine & Minnan PET Center, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Teaching Hospital of Fujian Medical University, Xiamen, China. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2565-2566. Date of Electronic Publication: 2023 Feb 28.
Typ publikacji:
Journal Article
MeSH Terms:
Histiocytosis, Sinus*/diagnostic imaging
Quinolines*
Humans ; Positron Emission Tomography Computed Tomography ; Gallium Radioisotopes ; Pulmonary Artery/diagnostic imaging ; Positron-Emission Tomography ; Fluorodeoxyglucose F18
Czasopismo naukowe
Tytuł:
Identification of a CEACAM5 targeted nanobody for positron emission tomography imaging and near-infrared fluorescence imaging of colorectal cancer.
Autorzy:
Xiao Y; Department of Nuclear Medicine, The Fifth Affiliated Hospital, Sun Yat-Sen University, Guangdong Province, 519000, China.; Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-Sen University, Guangdong Province, 519000, China.
Mei C; Department of Nuclear Medicine, The Fifth Affiliated Hospital, Sun Yat-Sen University, Guangdong Province, 519000, China.; Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-Sen University, Guangdong Province, 519000, China.
Xu D; Department of Nuclear Medicine, The Fifth Affiliated Hospital, Sun Yat-Sen University, Guangdong Province, 519000, China.; Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-Sen University, Guangdong Province, 519000, China.
Yang F; Department of Nuclear Medicine, The Fifth Affiliated Hospital, Sun Yat-Sen University, Guangdong Province, 519000, China.; Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-Sen University, Guangdong Province, 519000, China.
Yang M; Department of Nuclear Medicine, The Fifth Affiliated Hospital, Sun Yat-Sen University, Guangdong Province, 519000, China.; Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-Sen University, Guangdong Province, 519000, China.
Bi L; Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-Sen University, Guangdong Province, 519000, China.
Mao J; Center for Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-Sen University, Guangdong Province, 519000, China. .
Pang P; Center for Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-Sen University, Guangdong Province, 519000, China. .
Li D; Department of Nuclear Medicine, The Fifth Affiliated Hospital, Sun Yat-Sen University, Guangdong Province, 519000, China. .; Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-Sen University, Guangdong Province, 519000, China. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2305-2318. Date of Electronic Publication: 2023 Mar 14.
Typ publikacji:
Journal Article
MeSH Terms:
Single-Domain Antibodies*/metabolism
Colorectal Neoplasms*/diagnostic imaging
Humans ; Cell Line, Tumor ; Positron-Emission Tomography ; Optical Imaging ; Carcinoembryonic Antigen ; GPI-Linked Proteins
Czasopismo naukowe
Tytuł:
Comparison of two hybrid sentinel node tracers: indocyanine green (ICG)- Tc-nanoscan from a nuclear medicine and surgical perspective.
Autorzy:
Vreeburg MTA; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Hospital, Leiden, The Netherlands.
Azargoshasb S; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Hospital, Leiden, The Netherlands.
van Willigen D; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Hospital, Leiden, The Netherlands.
Molenaar T; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Hospital, Leiden, The Netherlands.; Radiochemistry Facility, Department of Radiology, Leiden University Medical Hospital, Leiden, The Netherlands.
van Oosterom MN; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Hospital, Leiden, The Netherlands.
Buckle T; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Hospital, Leiden, The Netherlands.
Slof LJ; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Hospital, Leiden, The Netherlands.; Instrumentele zaken ontwikkeling, facilitair bedrijf, Leiden University Medical Centre, Leiden, The Netherlands.
Klop M; Department of Head and Neck Surgery, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Karakullukcu B; Department of Head and Neck Surgery, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Donswijk M; Department of Nuclear Medicine, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
van der Poel HG; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Hospital, Leiden, The Netherlands.
van Leeuwen FWB; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Hospital, Leiden, The Netherlands.
Brouwer OR; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Hospital, Leiden, The Netherlands.
Rietbergen DDD; Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Hospital, Leiden, The Netherlands. .; Department of Radiology, Section Nuclear Medicine, Leiden University Medical Hospital, Leiden, The Netherlands. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2282-2291. Date of Electronic Publication: 2023 Mar 17.
Typ publikacji:
Journal Article
MeSH Terms:
Nuclear Medicine*
Sentinel Lymph Node*/surgery
Melanoma*/diagnostic imaging
Melanoma*/surgery
Melanoma*/pathology
Penile Neoplasms*/pathology
Male ; Humans ; Indocyanine Green ; Sentinel Lymph Node Biopsy/methods ; Retrospective Studies ; Radiopharmaceuticals ; Lymphatic Metastasis ; Technetium Tc 99m Aggregated Albumin
Czasopismo naukowe
Tytuł:
First-in-human imaging using [ C]MDTC: a radiotracer targeting the cannabinoid receptor type 2.
Autorzy:
Du Y; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Coughlin JM; Department of Psychiatry and Behavioral Sciences, Johns Hopkins Medical Institutions, Baltimore, MD, 21287, USA.
Brosnan MK; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Chen A; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Shinehouse LK; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Abdallah R; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Lodge MA; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Mathews WB; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Liu C; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Wu Y; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Minn I; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Finley P; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Hall AW; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Lesniak WG; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Dannals RF; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Horti AG; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA.
Pomper MG; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N. Caroline St., JHOC 3223, Baltimore, MD, 21287, USA. .; Department of Psychiatry and Behavioral Sciences, Johns Hopkins Medical Institutions, Baltimore, MD, 21287, USA. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2386-2393. Date of Electronic Publication: 2023 Mar 06.
Typ publikacji:
Journal Article
MeSH Terms:
Positron Emission Tomography Computed Tomography*
Radiopharmaceuticals*/pharmacokinetics
Adult ; Humans ; Animals ; Mice ; Reproducibility of Results ; Positron-Emission Tomography/methods ; Brain/diagnostic imaging ; Brain/metabolism ; Receptors, Cannabinoid/metabolism
Czasopismo naukowe
Tytuł:
Rabbit fever: granulomatous inflammation by Francisella tularensis mimics lung cancer in dual tracer Ga-FAPI PET/CT.
Autorzy:
Meetschen M; Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany. .
Sandach P; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
Darwiche K; Department of Pulmonary Medicine, Section of Interventional Pneumology, Ruhrlandklinik, University Hospital Essen, Essen, Germany.
Theegarten D; Institute of Pathology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Moter A; Institute of Microbiology, Infectious Diseases and Immunology, Biofilmcenter Charité-Universitätsmedizin Berlin, Berlin, Germany.; Moter Diagnostics, Berlin, Germany.
Schaarschmidt BM; Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
Fendler WP; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
Hautzel H; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
Opitz M; Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2567-2569. Date of Electronic Publication: 2023 Mar 13.
Typ publikacji:
Journal Article
MeSH Terms:
Francisella tularensis*
Lung Neoplasms*/diagnostic imaging
Quinolines*
Animals ; Rabbits ; Fluorodeoxyglucose F18 ; Gallium Radioisotopes ; Positron Emission Tomography Computed Tomography ; Inflammation/diagnostic imaging
Czasopismo naukowe
Tytuł:
Radionuclide-based theranostics - a promising strategy for lung cancer.
Autorzy:
Zhu T; Department of Respiratory Medicine, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, 322000, Zhejiang, China.; Lingang Laboratory, Shanghai, 200031, China.
Hsu JC; Departments of Radiology and Medical Physics, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Guo J; Department of Interventional Medicine, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, 519000, Guangdong, China.
Chen W; Department of Respiratory Medicine, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, 322000, Zhejiang, China. .; International Institutes of Medicine, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, Zhejiang, China. .
Cai W; Departments of Radiology and Medical Physics, University of Wisconsin-Madison, Madison, WI, 53705, USA. .
Wang K; Department of Respiratory Medicine, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, 322000, Zhejiang, China. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2353-2374. Date of Electronic Publication: 2023 Mar 16.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Precision Medicine*
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/radiotherapy
Humans ; Radioisotopes/therapeutic use ; Diagnostic Imaging ; Radiopharmaceuticals/therapeutic use
Czasopismo naukowe
Tytuł:
A radiohybrid theranostics ligand labeled with fluorine-18 and lutetium-177 for fibroblast activation protein-targeted imaging and radionuclide therapy.
Autorzy:
Yang T; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, #58 Zhongshan Er Road, Guangzhou, 510080, Guangdong Province, China.
Peng L; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, #58 Zhongshan Er Road, Guangzhou, 510080, Guangdong Province, China.
Qiu J; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, #58 Zhongshan Er Road, Guangzhou, 510080, Guangdong Province, China.
He X; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, #58 Zhongshan Er Road, Guangzhou, 510080, Guangdong Province, China.
Zhang D; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, #58 Zhongshan Er Road, Guangzhou, 510080, Guangdong Province, China.
Wu R; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, #58 Zhongshan Er Road, Guangzhou, 510080, Guangdong Province, China.
Liu J; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, #58 Zhongshan Er Road, Guangzhou, 510080, Guangdong Province, China.
Zhang X; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, #58 Zhongshan Er Road, Guangzhou, 510080, Guangdong Province, China. .
Zha Z; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, #58 Zhongshan Er Road, Guangzhou, 510080, Guangdong Province, China. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2331-2341. Date of Electronic Publication: 2023 Mar 03.
Typ publikacji:
Journal Article
MeSH Terms:
Precision Medicine*
Neoplasms*
Mice ; Animals ; Humans ; Tissue Distribution ; Ligands ; Mice, Nude ; Positron-Emission Tomography ; Fluorine Radioisotopes/chemistry ; Gallium Radioisotopes/chemistry ; Fibroblasts ; Cell Line, Tumor ; Positron Emission Tomography Computed Tomography/methods
Czasopismo naukowe
Tytuł:
Optimisation of scan duration and image quality in oncological Zr immunoPET imaging using the Biograph Vision PET/CT.
Autorzy:
van Sluis J; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands. .
Boellaard R; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.; Department of Radiology and Nuclear Medicine, University Medical Centers Amsterdam, Free University of Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Dierckx RAJO; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
van Esch ELM; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Croes DA; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
de Ruijter LK; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
van de Donk PP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Noordzij W; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Brouwers AH; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2258-2270. Date of Electronic Publication: 2023 Mar 22.
Typ publikacji:
Journal Article; Comment
MeSH Terms:
Positron Emission Tomography Computed Tomography*/methods
Neoplasms*/diagnostic imaging
Humans ; Reference Standards ; Antibodies, Monoclonal ; Positron-Emission Tomography/methods ; Image Processing, Computer-Assisted
Czasopismo naukowe
Tytuł:
Efficacy of [ Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study.
Autorzy:
Mitjavila M; Department of Nuclear Medicine, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Jimenez-Fonseca P; Department of Medical Oncology, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain.
Belló P; Department of Nuclear Medicine, Hospital Universitario La Fe, Valencia, Spain.
Pubul V; Department of Nuclear Medicine, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.
Percovich JC; Department of Endocrinology and Nutrition, Hospital Universitario Gregorio Marañón, Madrid, Spain.
Garcia-Burillo A; Department of Nuclear Medicine, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
Hernando J; Department of Medical Oncology, Hospital Universitario Vall d'Hebron, Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Arbizu J; Department of Nuclear Medicine, Clínica Universidad de Navarra, Pamplona, Spain.
Rodeño E; Department of Nuclear Medicine, Hospital Universitario de Cruces, Bilbao, Spain.
Estorch M; Department of Nuclear Medicine, Hospital de la Santa Creu i San Pau, Barcelona, Spain.
Llana B; Department of Nuclear Medicine, Hospital Universitario Central de Asturias, Oviedo, Spain.
Castellón M; Department of Nuclear Medicine, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.
García-Cañamaque L; Department of Nuclear Medicine, Hospital HM Sanchinarro, Madrid, Spain.
Gajate P; Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Riesco MC; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Miguel MB; Department of Nuclear Medicine, Hospital Universitario de Burgos, Burgos, Spain.
Balaguer-Muñoz D; Department of Nuclear Medicine, Hospital Universitario Doctor Peset, Valencia, Spain.
Custodio A; Department of Medical Oncology, Hospital Universitario La Paz, CIBERONC CB16/12/00398, Madrid, Spain.
Cano JM; Department of Medical Oncology, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.
Repetto A; Department of Nuclear Medicine, Hospital Universitario Son Espases, Mallorca, Spain.
Garcia-Alonso P; Department of Nuclear Medicine, Hospital Universitario de Getafe, Madrid, Spain.
Muros MA; Department of Nuclear Medicine, Hospital Universitario Virgen de las Nieves, Granada, Spain.
Vercher-Conejero JL; Department of Nuclear Medicine-PET Unit, Hospital Universitario de Bellvitge - IDIBELL, Barcelona, Spain.
Carmona-Bayonas A; Department of Medical Oncology, Hospital Universitario Morales Meseguer, University de Murcia, IMIB, Murcia, Spain. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2486-2500. Date of Electronic Publication: 2023 Mar 06.
Typ publikacji:
Journal Article
MeSH Terms:
Neuroendocrine Tumors*/pathology
Pheochromocytoma*
Paraganglioma*
Adrenal Gland Neoplasms*
Organometallic Compounds*/adverse effects
Humans ; Octreotide/adverse effects ; Prognosis ; Receptors, Somatostatin
Czasopismo naukowe
Tytuł:
Deep learning for improving PET/CT attenuation correction by elastic registration of anatomical data.
Autorzy:
Schaefferkoetter J; Siemens Medical Solutions USA, Inc., 810 Innovation Drive, Knoxville, TN, 37932, USA. .
Shah V; Siemens Medical Solutions USA, Inc., 810 Innovation Drive, Knoxville, TN, 37932, USA.
Hayden C; Siemens Medical Solutions USA, Inc., 810 Innovation Drive, Knoxville, TN, 37932, USA.
Prior JO; Department of Nuclear and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland.; University of Lausanne, Lausanne, Switzerland.
Zuehlsdorff S; Siemens Medical Solutions USA, Inc., 810 Innovation Drive, Knoxville, TN, 37932, USA.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2292-2304. Date of Electronic Publication: 2023 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Positron Emission Tomography Computed Tomography*/methods
Deep Learning*
Humans ; Movement ; Positron-Emission Tomography/methods ; Radionuclide Imaging ; Artifacts ; Image Processing, Computer-Assisted/methods
Czasopismo naukowe
Tytuł:
Metabolic patterns on [ F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment.
Autorzy:
Holzgreve A; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. .
Taugner J; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Käsmann L; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Member of the German Center for Lung Research (DZL), Comprehensive Pneumology Center Munich (CPC-M), Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
Müller P; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
Tufman A; Member of the German Center for Lung Research (DZL), Comprehensive Pneumology Center Munich (CPC-M), Munich, Germany.; Department of Internal Medicine V, University Hospital, LMU Munich, Munich, Germany.
Reinmuth N; Asklepios Lung Clinic, Munich‑Gauting, Germany.
Li M; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Winkelmann M; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
Unterrainer LM; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Nieto AE; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Bartenstein P; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
Kunz WG; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
Ricke J; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
Belka C; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Member of the German Center for Lung Research (DZL), Comprehensive Pneumology Center Munich (CPC-M), Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
Eze C; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Unterrainer M; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
Manapov F; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Member of the German Center for Lung Research (DZL), Comprehensive Pneumology Center Munich (CPC-M), Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2466-2476. Date of Electronic Publication: 2023 Mar 23.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/diagnostic imaging
Carcinoma, Non-Small-Cell Lung*/therapy
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/therapy
Humans ; Positron Emission Tomography Computed Tomography ; Fluorodeoxyglucose F18 ; Treatment Outcome ; Chemoradiotherapy/adverse effects
Czasopismo naukowe
Tytuł:
Machine learning radiomics to predict the early recurrence of intrahepatic cholangiocarcinoma after curative resection: A multicentre cohort study.
Autorzy:
Bo Z; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Chen B; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Yang Y; Department of Epidemiology and Biostatistics, School of Public Health and Management, Wenzhou Medical University, Wenzhou, China.
Yao F; Department of Radiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Mao Y; Department of Optometry and Ophthalmology College, Wenzhou Medical University, Wenzhou, China.
Yao J; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Yang J; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
He Q; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Zhao Z; Department of Oncology, the First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Shi X; Department of Hepatobiliary Surgery, the Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
Chen J; Department of General Surgery, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Yu Z; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Yang Y; Department of Radiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. .
Wang Y; Department of Epidemiology and Biostatistics, School of Public Health and Management, Wenzhou Medical University, Wenzhou, China. .
Chen G; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. .; Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2501-2513. Date of Electronic Publication: 2023 Mar 16.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Cholangiocarcinoma*/diagnostic imaging
Cholangiocarcinoma*/surgery
Bile Duct Neoplasms*/diagnostic imaging
Bile Duct Neoplasms*/surgery
Humans ; Male ; Retrospective Studies ; Machine Learning ; Bile Ducts, Intrahepatic
Czasopismo naukowe
Tytuł:
Prospective validation of tumor folate receptor expression density with the association of pafolacianine fluorescence during intraoperative molecular imaging-guided lung cancer resections.
Autorzy:
Azari F; Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, 3400 Spruce Street, 6 White Building, Philadelphia, PA, 19104, USA.
Zhang K; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Kennedy G; Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, 3400 Spruce Street, 6 White Building, Philadelphia, PA, 19104, USA.
Bou-Samra P; Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, 3400 Spruce Street, 6 White Building, Philadelphia, PA, 19104, USA.; Ohio State University School of Medicine, Ohio, Columbus, USA.
Chang A; Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, 3400 Spruce Street, 6 White Building, Philadelphia, PA, 19104, USA.
Nadeem B; Ankara Yildirim Beyazit Faculty of Medicine, Ankara, Turkey.
Chang A; Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, 3400 Spruce Street, 6 White Building, Philadelphia, PA, 19104, USA.
Galandarova A; Ankara Yildirim Beyazit Faculty of Medicine, Ankara, Turkey.
Ibrahimli A; Faculty of Medicine, Ankara University, Ankara, Turkey.
Karimov Z; Faculty of Medicine, Ege University, Izimir, Turkey.
Din A; Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, 3400 Spruce Street, 6 White Building, Philadelphia, PA, 19104, USA.
Kucharczuk J; Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, 3400 Spruce Street, 6 White Building, Philadelphia, PA, 19104, USA.
Doraid J; Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, 3400 Spruce Street, 6 White Building, Philadelphia, PA, 19104, USA.
Pechet T; Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, 3400 Spruce Street, 6 White Building, Philadelphia, PA, 19104, USA.
Delikatny E; Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Singhal S; Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, 3400 Spruce Street, 6 White Building, Philadelphia, PA, 19104, USA. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2453-2465. Date of Electronic Publication: 2023 Mar 11.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/surgery
Lung Neoplasms*/metabolism
Adenocarcinoma*/pathology
Carcinoma, Squamous Cell*
Humans ; Prospective Studies ; Folic Acid ; Molecular Imaging/methods
Czasopismo naukowe
Tytuł:
SPECT and CT misregistration reduction in [ Tc]Tc-MAA SPECT/CT for precision liver radioembolization treatment planning.
Autorzy:
Lu Z; Biomedical Imaging Laboratory (BIG), Department of Electrical and Computer Engineering, Faculty of Science and Technology, University of Macau, Taipa, Macau SAR, China.; Center for Cognitive and Brain Sciences, Institute of Collaborative Innovation, University of Macau, Taipa, Macau SAR, China.
Chen G; Biomedical Imaging Laboratory (BIG), Department of Electrical and Computer Engineering, Faculty of Science and Technology, University of Macau, Taipa, Macau SAR, China.
Jiang H; Biomedical Imaging Laboratory (BIG), Department of Electrical and Computer Engineering, Faculty of Science and Technology, University of Macau, Taipa, Macau SAR, China.
Sun J; Biomedical Imaging Laboratory (BIG), Department of Electrical and Computer Engineering, Faculty of Science and Technology, University of Macau, Taipa, Macau SAR, China.
Lin KH; Department of Nuclear Medicine, Taipei Veterans General Hospital, Taipei, 11217, Taiwan. .
Mok GSP; Biomedical Imaging Laboratory (BIG), Department of Electrical and Computer Engineering, Faculty of Science and Technology, University of Macau, Taipa, Macau SAR, China. .; Center for Cognitive and Brain Sciences, Institute of Collaborative Innovation, University of Macau, Taipa, Macau SAR, China. .; Ministry of Education Frontiers Science Center for Precision Oncology, Faculty of Health Science, University of Macau, Taipa, Macau SAR, China. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2319-2330. Date of Electronic Publication: 2023 Mar 06.
Typ publikacji:
Journal Article
MeSH Terms:
Embolization, Therapeutic*/methods
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/radiotherapy
Humans ; Tomography, Emission-Computed, Single-Photon/methods ; Single Photon Emission Computed Tomography Computed Tomography ; Technetium Tc 99m Aggregated Albumin ; Yttrium Radioisotopes/therapeutic use ; Microspheres ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Multicentric development and evaluation of F-FDG PET/CT and MRI radiomics models to predict para-aortic lymph node involvement in locally advanced cervical cancer.
Autorzy:
Lucia F; Radiation Oncology Department, University Hospital, Brest, France. .; LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France. .; Division of Nuclear Medicine and Oncological Imaging, University Hospital of Liège, Liège, Belgium. .
Bourbonne V; Radiation Oncology Department, University Hospital, Brest, France.; LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.
Pleyers C; Department of Radiotherapy Oncology, University Hospital of Liège, Liège, Belgium.
Dupré PF; Department of Gynecology and Surgery, University Hospital, Brest, France.
Miranda O; Radiation Oncology Department, University Hospital, Brest, France.
Visvikis D; LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.
Pradier O; Radiation Oncology Department, University Hospital, Brest, France.; LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.
Abgral R; Nuclear Medicine Department, University Hospital, Brest, France.; EA GETBO 3878, IFR 148, University of Brest, UBO, Brest, France.
Mervoyer A; Department of Radiation Oncology, Institut de Cancérologie de l'Ouest Centre René Gauducheau, Saint Herblain, France.
Classe JM; Department of Surgical Oncology, Institut de Cancérologie de l'Ouest Centre René Gauducheau, Saint Herblain, France.
Rousseau C; Université de Nantes, CNRS, Inserm, CRCINA, F-44000, Nantes, France.; ICO René Gauducheau, F-44800, Saint-Herblain, France.
Vos W; Radiomics SA, Liège, Belgium.
Hermesse J; Department of Radiotherapy Oncology, University Hospital of Liège, Liège, Belgium.
Gennigens C; Department of Medical Oncology, University Hospital of Liège, Liège, Belgium.
De Cuypere M; Department of Gynecology, University Hospital of Liège, Liège, Belgium.
Kridelka F; Department of Gynecology, University Hospital of Liège, Liège, Belgium.
Schick U; Radiation Oncology Department, University Hospital, Brest, France.; LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.
Hatt M; LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.
Hustinx R; Division of Nuclear Medicine and Oncological Imaging, University Hospital of Liège, Liège, Belgium.
Lovinfosse P; Division of Nuclear Medicine and Oncological Imaging, University Hospital of Liège, Liège, Belgium.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2514-2528. Date of Electronic Publication: 2023 Mar 09.
Typ publikacji:
Journal Article
MeSH Terms:
Positron Emission Tomography Computed Tomography*/methods
Uterine Cervical Neoplasms*/diagnostic imaging
Uterine Cervical Neoplasms*/therapy
Uterine Cervical Neoplasms*/pathology
Female ; Humans ; Fluorodeoxyglucose F18 ; Retrospective Studies ; Lymph Nodes/diagnostic imaging ; Lymph Nodes/pathology ; Magnetic Resonance Imaging
Czasopismo naukowe
Tytuł:
[ Lu]Lu-PSMA-617 theranostic probe for hepatocellular carcinoma imaging and therapy.
Autorzy:
Lu Q; Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China.; Hubei Key Laboratory of Molecular Imaging, Wuhan, Hubei, 430022, China.
Long Y; Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China.; Hubei Key Laboratory of Molecular Imaging, Wuhan, Hubei, 430022, China.
Gai Y; Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China.; Hubei Key Laboratory of Molecular Imaging, Wuhan, Hubei, 430022, China.; Key Laboratory of Biological Targeted Therapy of the Ministry of Education, Wuhan, 430022, China.
Liu Q; Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China.; Hubei Key Laboratory of Molecular Imaging, Wuhan, Hubei, 430022, China.; Key Laboratory of Biological Targeted Therapy of the Ministry of Education, Wuhan, 430022, China.
Jiang D; Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China.; Hubei Key Laboratory of Molecular Imaging, Wuhan, Hubei, 430022, China.; Key Laboratory of Biological Targeted Therapy of the Ministry of Education, Wuhan, 430022, China.
Lan X; Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China. xiaoli_.; Hubei Key Laboratory of Molecular Imaging, Wuhan, Hubei, 430022, China. xiaoli_.; Key Laboratory of Biological Targeted Therapy of the Ministry of Education, Wuhan, 430022, China. xiaoli_.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2342-2352. Date of Electronic Publication: 2023 Mar 06.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/radiotherapy
Carcinoma, Hepatocellular*/drug therapy
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/radiotherapy
Liver Neoplasms*/drug therapy
Prostatic Neoplasms, Castration-Resistant*/drug therapy
Male ; Humans ; Animals ; Mice ; Precision Medicine ; Tissue Distribution ; Prostate-Specific Antigen ; Dipeptides ; Heterocyclic Compounds, 1-Ring ; Radiopharmaceuticals/pharmacokinetics ; Lutetium/therapeutic use ; Lutetium/pharmacokinetics ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml.
Autorzy:
Solomonidou N; Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.
Germanou D; Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.
Strouthos I; Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.
Karagiannis E; Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.
Farolfi A; Division of Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Koerber SA; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.
Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.
Peeken JC; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.; Department of Radiation Sciences (DRS), Institute of Radiation Medicine (IRM), Helmholtz Zentrum, Munich, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.
Vogel ME; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.; Department of Radiation Sciences (DRS), Institute of Radiation Medicine (IRM), Helmholtz Zentrum, Munich, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.
Vrachimis A; Department of Nuclear Medicine, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.; C.A.R.I.C. Cancer Research & Innovation Center, Limassol, Cyprus.
Spohn SKB; Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg im Breisgau, Germany.; Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Shelan M; Department of Radiation Oncology, Inselspital Bern, University of Bern, Bern, Switzerland.
Aebersold D; Department of Radiation Oncology, Inselspital Bern, University of Bern, Bern, Switzerland.
Grosu AL; Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg im Breisgau, Germany.
Ceci F; Division of Nuclear Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Kroeze SGC; Northern Sydney Cancer Centre, Royal North Shore Hospital, University of Sydney, Sydney, New South Wales, Australia.
Guckenberger M; Northern Sydney Cancer Centre, Royal North Shore Hospital, University of Sydney, Sydney, New South Wales, Australia.
Fanti S; Division of Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Belka C; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Hruby G; Northern Sydney Cancer Centre, Royal North Shore Hospital, University of Sydney, Sydney, New South Wales, Australia.
Scharl S; Department of Radiation Oncology, University of Ulm, Ulm, Germany.
Wiegel T; Department of Radiation Oncology, University of Ulm, Ulm, Germany.
Bartenstein P; Department of Nuclear MedicineUniversity Hospital, LMU Munich, Munich, Germany.
Henkenberens C; Department of Radiotherapy and Special Oncology, Medical School Hannover, Hannover, Germany.
Emmett L; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital, Sydney, Australia.; St Vincent's Clinical School, University of New South Wales, Sydney, Australia.
Schmidt-Hegemann NS; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Ferentinos K; Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.
Zamboglou C; Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany. .; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg im Breisgau, Germany. .; Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany. .; German Oncology Center, University Hospital of the European University Cyprus, Limassol, Cyprus. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2529-2536. Date of Electronic Publication: 2023 Mar 11.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/surgery
Male ; Humans ; Prostate-Specific Antigen ; Positron Emission Tomography Computed Tomography/methods ; Gallium Radioisotopes ; Retrospective Studies ; Androgen Antagonists ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/radiotherapy ; Salvage Therapy ; Prostatectomy
Czasopismo naukowe
Tytuł:
An exploration of the feasibility and clinical value of half-dose 5-h total-body F-FDG PET/CT scan in patients with Takayasu arteritis.
Autorzy:
Adili D; Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.; Nuclear Medicine Institute of Fudan University, Shanghai, 200032, China.; Shanghai Institute of Medical Imaging, Shanghai, 200032, China.; Cancer Prevention and Treatment Center, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Cai D; Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.; Nuclear Medicine Institute of Fudan University, Shanghai, 200032, China.; Shanghai Institute of Medical Imaging, Shanghai, 200032, China.; Cancer Prevention and Treatment Center, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Wu B; Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.; Nuclear Medicine Institute of Fudan University, Shanghai, 200032, China.; Shanghai Institute of Medical Imaging, Shanghai, 200032, China.; Cancer Prevention and Treatment Center, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Yu H; Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.; Nuclear Medicine Institute of Fudan University, Shanghai, 200032, China.; Shanghai Institute of Medical Imaging, Shanghai, 200032, China.; Cancer Prevention and Treatment Center, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Gu Y; Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.; Nuclear Medicine Institute of Fudan University, Shanghai, 200032, China.; Shanghai Institute of Medical Imaging, Shanghai, 200032, China.; Cancer Prevention and Treatment Center, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Zhang Y; Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. .; Nuclear Medicine Institute of Fudan University, Shanghai, 200032, China. .; Shanghai Institute of Medical Imaging, Shanghai, 200032, China. .; Cancer Prevention and Treatment Center, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. .
Shi H; Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. .; Nuclear Medicine Institute of Fudan University, Shanghai, 200032, China. .; Shanghai Institute of Medical Imaging, Shanghai, 200032, China. .; Cancer Prevention and Treatment Center, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2375-2385. Date of Electronic Publication: 2023 Mar 03.
Typ publikacji:
Journal Article
MeSH Terms:
Fluorodeoxyglucose F18*
Takayasu Arteritis*/diagnostic imaging
Humans ; Positron Emission Tomography Computed Tomography/methods ; Radiopharmaceuticals ; Feasibility Studies ; Positron-Emission Tomography/methods
Czasopismo naukowe
Tytuł:
Diagnostic effectiveness of [ F]Fluoroestradiol PET/CT in oestrogen receptor-positive breast cancer: the key role of histopathology. Evidence from an international multicentre prospective study.
Autorzy:
Bottoni G; Department of Nuclear Medicine, E.O. 'Ospedali Galliera', Mura delle Cappuccine 14, 16128, Italy.
Fiz F; Department of Nuclear Medicine, E.O. 'Ospedali Galliera', Mura delle Cappuccine 14, 16128, Italy. .
Puntoni M; Clinical and Epidemiological Research Unit, University Hospital of Parma, Parma, Italy.
Matteucci F; Nuclear Medicine Unit, IRCCS Istituto Romagnolo per lo studio dei tumori (IRST)- Dino Amadori, Meldola, Italy.
Monti M; Biostatistics and Clinical Trials Unit, IRCCS Istituto Romagnolo per lo studio dei tumori (IRST)- Dino Amadori_, Meldola, Italy.
DeCensi A; Department of Medicine and Oncology, E.O. 'Ospedali Galliera', Genoa, Italy.
Nanni O; Biostatistics and Clinical Trials Unit, Istituto Scientifico Romagnolo per lo studio e la cura dei tumori, IRST, Meldola, Italy.
Brain E; Department of Clinical Research & Medical Oncology, Institut Curie (Hôpital René Huguenin), St Cloud, France.
Alberini JL; Nuclear Medicine Department Centre Georges-Francois Leclerc, 1 rue du Pr Marion, 21079, Dijon Cedex, France.
Dib B; Nuclear Medicine Unit, AOU Maggiore della Carità, Novara, Italy.
Sacchetti G; Nuclear Medicine Unit, AOU Maggiore della Carità, Novara, Italy.
Trimboli P; Clinic of Endocrinology and Diabetology, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland.
Treglia G; Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland.; Clinic of Nuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, 6500, Bellinzona, Switzerland.; Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne, 1015, Lausanne, Switzerland.
Harbeck N; Breast Centre, Department of Obstetrics and Gynaecology, LMU University Hospital, Munich, Germany.
Sola S; Pathology Unit, E.O. 'Ospedali Galliera', Genoa, Italy.
Gennari A; Department of Translational Oncology, University of Eastern Piedmont, Novara, Italy.
Piccardo A; Department of Nuclear Medicine, E.O. 'Ospedali Galliera', Mura delle Cappuccine 14, 16128, Italy.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2477-2485. Date of Electronic Publication: 2023 Mar 07.
Typ publikacji:
Multicenter Study; Journal Article; Comment
MeSH Terms:
Breast Neoplasms*/diagnostic imaging
Breast Neoplasms*/pathology
Humans ; Female ; Positron Emission Tomography Computed Tomography/methods ; Receptors, Estrogen ; Prospective Studies ; Fluorodeoxyglucose F18 ; Estradiol
Czasopismo naukowe
Tytuł:
Characterization of neuroinflammation pattern in anti-LGI1 encephalitis based on TSPO PET and symptom clustering analysis.
Autorzy:
Wang J; Department of Neurology and Institute of Neurology, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.; National Center for Neurological Disorders, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.
Ge J; Department of Nuclear Medicine/PET Center, Huashan Hospital, Fudan University, 518 East Wuzhong Road, Shanghai, 200235, China.
Jin L; Department of Neurology and Institute of Neurology, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.; National Center for Neurological Disorders, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.
Deng B; Department of Neurology and Institute of Neurology, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.; National Center for Neurological Disorders, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.
Tang W; Department of Radiology, Huashan Hospital, Shanghai, 200040, China.
Yu H; Department of Neurology and Institute of Neurology, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.; National Center for Neurological Disorders, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.
Zhang X; Department of Neurology and Institute of Neurology, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.; National Center for Neurological Disorders, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.
Liu X; Department of Neurology and Institute of Neurology, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.; National Center for Neurological Disorders, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.
Xue L; Department of Nuclear Medicine, the Second Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.
Zuo C; Department of Nuclear Medicine/PET Center, Huashan Hospital, Fudan University, 518 East Wuzhong Road, Shanghai, 200235, China. .
Chen X; Department of Neurology and Institute of Neurology, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China. .; National Center for Neurological Disorders, 12 Wulumuqi Zhong Road, Shanghai, 200040, China. .; Human Phenome Institute, Fudan University, Shanghai, China. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2394-2408. Date of Electronic Publication: 2023 Mar 17.
Typ publikacji:
Journal Article
MeSH Terms:
Encephalitis*/diagnostic imaging
Glioma*
Autoimmune Diseases of the Nervous System*
Humans ; Neuroinflammatory Diseases ; Leucine ; Intracellular Signaling Peptides and Proteins ; Seizures ; Positron-Emission Tomography/methods ; Receptors, GABA
SCR Disease Name:
Hashimoto's encephalitis
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies